By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Discovery, development and manufacturing of a comprehensive pipeline of immunological agents33.74M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States113.16M99.09%
Rest of world1.04M0.91%